- IN₹55.14bn
- IN₹49.98bn
- IN₹21.71bn
Brief: F D C Ltd To Consider Share Buyback Via Tender Offer Route
Brief: F D C Ltd Gets ANDA Approval For Ofloxacin Otic Solution, 0.3% From U.S. FDA
Brief: F D C Ltd Sept-Quarter Consol Net Profit Falls
Brief: F D C Says Received Good Manufacturing Practice Certificate
Brief: India's F D C Ltd June-Quarter Consol Net Profit Rises
Brief: India's F D C Ltd Consol Dec Quarter Profit Rises
In Process To Expand Production Capacity At Waluj, Maharashtra
Brief: FDC Ltd Says Launches Stronger Versions Of Favipiravir
Brief: India's FDC June Quarter Consol Profit Rises
Brief: India's FDC To Consider Share Buyback Via Tender Offer
Brief: India's FDC March-Qtr Consol Profit Rises
Brief: India's F D C Dec-Qtr Consol Profit Rises
Brief: FDC Gets GMP Certificate From UK MHRA For Oral Solid Dosage Form Facilities In Verna, Goa
Brief: India's FDC Sept Quarter Consol Profit Rises
Brief: FDC Ltd Says Fire Occurred At Roha, Maharashtra Plant On May 3
Brief: India's F D C Dec-Qtr Profit Rises
Brief: India's F D C Sept-Qtr Profit Falls
Brief: FDC Ltd Says Aurangabad Facility Considered Acceptable After FDA Inspection
India's FDC Ltd drops; says FDA conducted surprise inspection of facility